After gynecological cancers of the breast, cervix, uterus, and ovaries, vulvar cancer is the sixth most common type. Epidermoid carcinoma is the most typical histological form. However, the vulva, which is histologically defined as a collection of different tissues (cutaneous, glandular, adipocytes, muscular, and mucous), can experience a variety of modifications that can lead to lesions of various histological types, some of which may be uncommon, such as the synovial sarcoma of the vulva. There aren't many cases mentioned in the literature. Despite its name, Synovial Sarcoma (SS) is not of synovial origin; rather, it is produced from multipotent stem cells that have the capacity to differentiate into mesenchymal and epithelial cells. The most typical symptom is a localized pain or discomfort during intercourse, and the median age at diagnosis is 50. Frequently, these lesions are misdiagnosed as cysts or Bartholin abscesses. The surgical removal of the lesion with healthy tissue margins is the mainstay of treatment for synovial sarcoma. The outlook is not good. At two years, there is a 50% chance of locoregional recurrence or metastasis of SS. Local lymph nodes, lungs, bones, and liver are where metastatic lesions most frequently appear. A case of a 28-year-old lady who had vulvar synovial sarcoma is described in the current case report. This tumor management calls for a multidisciplinary approach.